STRATA Skin Sciences Inc
General ticker "SSKN" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $12.2M
STRATA Skin Sciences Inc does not follow the US Stock Market performance with the rate: -43.3%.
Estimated limits based on current volatility of 2.0%: low 2.88$, high 3.00$
Factors to consider:
- China accounted for 13.1% of revenue in the fiscal year ended 2022-12-31
- US accounted for 66.3% of revenue in the fiscal year ended 2022-12-31
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [3.12$, 7.44$]
- 2024-12-30 to 2025-12-30 estimated range: [3.11$, 7.25$]
Financial Metrics affecting the SSKN estimates:
- Negative: Non-GAAP EPS, $ of -2.31 <= 0.10
- Negative: Operating profit margin, % of -20.50 <= 1.03
- Negative: Operating cash flow per share per price, % of -2.69 <= 2.35
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0.19 <= 0.49
- Positive: -3.48 < Investing cash flow per share, $ of -1.44
- Positive: Interest expense per share, $ of 0.47 <= 0.74
Short-term SSKN quotes
Long-term SSKN plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $29.98MM | $36.16MM | $33.36MM |
Operating Expenses | $34.38MM | $40.81MM | $41.96MM |
Operating Income | $-4.40MM | $-4.65MM | $-8.60MM |
Non-Operating Income | $1.73MM | $-0.84MM | $-2.32MM |
Interest Expense | $0.31MM | $0.93MM | $1.64MM |
R&D Expense | $1.43MM | $1.03MM | $1.32MM |
Income(Loss) | $-2.67MM | $-5.49MM | $-10.92MM |
Taxes | $0.03MM | $0.06MM | $-0.09MM |
Profit(Loss) | $-2.71MM | $-5.55MM | $-10.83MM |
Stockholders Equity | $25.41MM | $21.83MM | $12.69MM |
Inventory | $3.49MM | $5.55MM | $2.67MM |
Assets | $46.59MM | $52.27MM | $42.02MM |
Operating Cash Flow | $1.51MM | $-1.11MM | $-0.52MM |
Capital expenditure | $3.65MM | $3.55MM | $5.02MM |
Investing Cash Flow | $-7.13MM | $-4.18MM | $-5.02MM |
Financing Cash Flow | $0.09MM | $-0.50MM | $6.86MM |
Earnings Per Share* | $-0.79 | $-1.60 | $-3.10 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.